Tools
Stock profile

AGILENT TECHNOLOGIES, INC. (A)

A · Latest close $177.33 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$177.33
As of Nov 18, 2026
Tracked funds holding
3 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
1
vs previous quarter

AGILENT TECHNOLOGIES, INC. (A) is held by 3 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding and 1 fund trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $96.0K sold). Latest close $177.33 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Sep 4, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-96.0K
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Cantillon Capital Management · Greenhaven Associates · Guinness Asset Management — 3 tracked funds hold A. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 1 sale ($96.0K). Insider trading

Often held alongside

WATERS CORP /DE/ (WAT) · Avantor, Inc. (AVTR) · BIO-RAD LABORATORIES, INC. (BIO) · ILLUMINA, INC. (ILMN) · METTLER TOLEDO INTERNATIONAL INC/ (MTD) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Cantillon Capital Management2.53%126,437TRIMMED (-95.4%)
Greenhaven Associates0.02%10,700HELD Q3 filed Oct 26
Guinness Asset Management0.01%3,653ADDED (+30.0%) Q3 filed Nov 5

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +29.1% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

181.4896.002024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding1,117 of 8,857 filers
Long-only filers among them1,116
Change vs 2026 Q1+70 net · 982 entered · 912 exited
Shares reported, all filers259,722,175
Reported value, all filers$33.0B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryLaboratory Analytical Instruments (SIC 3826)
Revenue · FY2025$6.9B
Net income · FY2025$1.3B
Total assets · FY2025$12.7B
Shares outstanding281,928,854
Market cap (at latest close)$50.0B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Aug 26, 2026.

Short interest

Shares short · Oct 15, 20265,025,670
Share of shares outstanding1.78%
Days to cover2.42

Shares short at recent settlements — Jul 31, 2026: 5.7M · Aug 14, 2026: 5.2M · Aug 31, 2026: 5.7M · Sep 15, 2026: 5.1M · Sep 30, 2026: 5.2M · Oct 15, 2026: 5.0M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Aug 26, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20262,008
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 2026<0.1%

Fails to deliver at recent settlements — Jul 31, 2026: 6K · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 2K.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Aug 26, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 1 sale by 1 insider ($96.0K).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Sep 4, 2026Dolsten MikaelSell634$151.38$96.0KSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Sep 4, 2026Dolsten MikaelDirector634$96.0KSep 4, 2026SEC filing
May 29, 2026Dolsten MikaelDirector1,600$216.7KMay 29, 2026SEC filing
Dec 1, 2025Dolsten MikaelDirector2,600$389.5KDec 1, 2025SEC filing
Nov 26, 2025Gonsalves RodneyOfficer3,000$465.0KNov 26, 2025SEC filing
Nov 18, 2025MCDONNELL PADRAIGOfficer, Director911$130.5KNov 18, 2025SEC filing
Nov 12, 2025MCDONNELL PADRAIGOfficer, Director12,490$1.9MNov 12, 2025SEC filing
Sep 9, 2025McMahon Robert W.Former Officer5,781$729.6KSep 9, 2025SEC filing
Sep 4, 2025McMahon Robert W.Former Officer15,303$2.0MSep 4, 2025SEC filing
Sep 2, 2025MCDONNELL PADRAIGOfficer, Director2,000$249.8KSep 2, 2025SEC filing
Aug 29, 2025McMahon Robert W.Former Officer28,081$3.5MAug 29, 2025SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Apr 29, 2026Vanguard Capital ManagementSC 13G21,189,6627.5%Mar 31, 2026SEC filing
Apr 28, 2026Vanguard Portfolio ManagementSC 13G14,387,1715.1%Mar 31, 2026SEC filing
Mar 26, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Apr 17, 2025BlackRock, Inc.SC 13G/A23,626,3468.3%Mar 31, 2025SEC filing
Feb 13, 2025Massachusetts Financial Services CompanySC 13G/A12,442,8344.4%Dec 31, 2024SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Laboratory Analytical Instruments (SIC 3826). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 121 Lobbying Disclosure Act filings named this company as client, 1999–2026; most common issues: Taxation/Internal Revenue Code (64), Government Issues (31), Defense (30).

Federal contracts: $269.6M in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$43.6M
FY2022$50.3M
FY2023$44.2M
FY2024$41.5M
FY2025$42.7M
FY2026$47.3M

Largest awards collected

Award IDAgencyAmountStart
15DDHQ19F00001471Department of Justice$524.9KSep 18, 2019
AG6395C150124Department of Agriculture$481.7KSep 23, 2015
75F40121P00388Department of Health and Human Services$305.3KAug 2, 2021
36C25726C0080Department of Veterans Affairs$295.2KJul 24, 2026
36C24422P0778Department of Veterans Affairs$227.6KAug 29, 2022

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Financial Screens

· Graham — Sound finances and a long run of profits

· Dividend Growth — Dividends raised for more than 10 years

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

· Earnings Stability — Small earnings swings and almost no loss years

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· Top Relative Strength — Top 20% of the universe by 6-month return

Key figures

· Graham — Current ratio: 1.96 · Straight profitable years: 16 · Debt ratio: — · Latest net income: $1.3B

· Dividend Growth — Dividend per share: 0.99 · Dividend yield: 0.5% · Straight dividend years: 14 · 10-yr dividend growth: 115.7%

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.33 · Operating cash flow: $1.6B · Net income: $1.3B

· Earnings Stability — Earnings variation (CV): 0.37 · Loss years (of 10): 0 · Latest net income: $1.3B

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Politician BEST — appeared in 1 of the last 20 quarterly lists; latest 2025 Q2, ranked #42 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together1100.0%+14.7%+5.6%+9.1%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold A — ranked by lift, the co-holding pattern described in Methodology: WATERS CORP /DE/ (WAT) · Avantor, Inc. (AVTR) · BIO-RAD LABORATORIES, INC. (BIO) · ILLUMINA, INC. (ILMN) · METTLER TOLEDO INTERNATIONAL INC/ (MTD) · BRUKER CORP (BRKR) · 908 Devices Inc. (MASS) · Quanterix Corp (QTRX).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Sep 8, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and ExhibitsSEC filing
Aug 26, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Jun 25, 20261.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

WATERS CORP /DE/ (WAT) · Track Record: how the signals scored · Practice timing on A

One email a week: the week’s new filings and research. Subscribe free

AA →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.